BREAKING NEWS: HGS rejects GSK $2.60 billion takeover bid

Article Date: 19/04/2012 10:03
BREAKING NEWS: HGS rejects GSK $2.60 billion takeover bid

Vacancy Search

Quick job search

Advanced Search

Latest News

EMA advisors back AbbVie, Celgene, Sanofi and BI drugs

EMA advisors back AbbVie, Celgene, Sanofi and BI drugs

SPONSORED COMMENT: Taking care of data

SPONSORED COMMENT: Taking care of data

SMARTTECH: Rise of robots in healthcare

SMARTTECH: Rise of robots in healthcare

Novartis gets CHMP backing for psoriasis drug Cosentyx

Novartis gets CHMP backing for psoriasis drug Cosentyx

Upcoming events: Sophiris data and US hep C approval for Bristol-Myers Squibb

Welcome to your weekly digest of approaching regulatory and clinical readouts. By the end of the year an interim analysis is expected from Sophiris Bio’s benign prostatic hyperplasia project...

FDA clears Purdue's abuse-deterrent painkiller

FDA clears Purdue's abuse-deterrent painkiller

EMA updates conflict of interest policy

EMA updates conflict of interest policy

UK launches innovative meds review as funds flow

UK launches innovative meds review as funds flow

Sanofi touts pipeline with 18 new drugs by 2020

Sanofi touts pipeline with 18 new drugs by 2020

Australia, NZ scrap plans for joint medicines regulator

Australia, NZ scrap plans for joint medicines regulator
more news